Direct-To-Patient

Digital

Integration: The key to scalable decentralised trials

Successful DCTs depend less on the technology deployed and more on how effectively those capabilities are integrated and executed.

Market Access

Direct-to-patient access: Five questions pharma must answer

Patients

Pharmacist with patient and prescription

From access to advocacy: Turning patients into brand champio...

Done right, DTP is not just filling scripts. It is building loyalty that turns satisfied patients into lifelong advocates.

Patients

Interview with Matt Wadyka at Reuters Pharma USA 2026

Making direct-to-patient work, with Matt Wadyka

Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.

Market Access

A panel on direct-to-patient at Reuters Pharma USA

In DTC's watershed moment, trust and partnership are key

More and more pharma companies are turning to direct-to-patient access models. But the consensus at Reuters Pharma USA is that they can't do it alone.

Patients

A female patient takes a pharmacy delivery directly

DTC pharma is America’s newest care pathway. TrumpRx has exp...

Today’s DTP platforms vary widely in standards, screening protocols, clinical follow-up, data use, and integration with a patient’s broader care team

Integration: The key to scalable decentralised trials

Direct-to-patient access: Five questions pharma must answer

From access to advocacy: Turning patients into brand champio...

Making direct-to-patient work, with Matt Wadyka

In DTC's watershed moment, trust and partnership are key

DTC pharma is America’s newest care pathway. TrumpRx has exp...

UK's Mission divests kidney drug to Dimerix for $292m

Discover a new era of healthcare panel engagement: Grounded ...

Direct-To-Patient

Editor's Picks